Philip Serlin

Philip Serlin

Chief Executive Officer chez BIOLINERX LTD.

Fortune : 13 138 $ au 31/03/2024

62 ans
Consumer Services
Health Technology
Technology Services

Profil

Philip Adam Serlin is currently the Chief Executive Officer at BioLineRx Ltd.
He previously served as an Independent Director at XWELL, Inc. from 2011 to 2012, an Independent Non-Executive Director at Vascular Biogenics Ltd., and an Independent Director at Purple Biotech Ltd.
from 2013 to 2016.
Additionally, he was the Chief Financial Officer at Tescom Software Systems Testing Ltd.
in 2007 and the Chief Operating & Financial Officer at Kayote Networks, Inc. in 2008.
He also held positions at Brightman Almagor Zohar & Co. and the US Securities & Exchange Commission.
Mr. Serlin holds a graduate degree from George Washington University and an undergraduate degree from Yeshiva University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/03/2024 171 900 ( 0,02% ) 13 138 $ 31/03/2024

Postes actifs de Philip Serlin

SociétésPosteDébut
BIOLINERX LTD. Chief Executive Officer 10/10/2016
Tous les postes actifs de Philip Serlin

Anciens postes connus de Philip Serlin

SociétésPosteFin
PURPLE BIOTECH LTD Director/Board Member 01/01/2016
XWELL, INC. Director/Board Member 19/07/2012
Director of Finance/CFO 01/08/2008
Director of Finance/CFO 01/12/2007
US Securities & Exchange Commission Corporate Officer/Principal -
Voir l'expérience en détail de Philip Serlin

Formation de Philip Serlin

George Washington University Graduate Degree
Yeshiva University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Philip Serlin

Relations

56

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
BIOLINERX LTD.

Health Technology

XWELL, INC.

Consumer Services

PURPLE BIOTECH LTD

Health Technology

Entreprise privées5

Technology Services

US Securities & Exchange Commission

Finance

Communications

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Philip Serlin